EVENTS
CHICAGO, IL – Jun 01 – Jun 03, 2019

Invivoscribe to Exhibit at ASCO 2019

EVENTS
CHICAGO, IL – Jun 01 – Jun 03, 2019

Invivoscribe to Exhibit at ASCO 2019

Join us at ASCO June 1st to June 3rd to speak to our team about Invivoscribe’s new products and assay offerings!

LymphoQuant® Internal Control
Minimal Residual Disease (MRD) is being increasingly recognized as a biomarker and potential surrogate endpoint for a number of hematologic malignancies. We at Invivoscribe are excited to share details on the release of LymphoQuant® for use with our LymphoTrack® assays to assess sample quality, qualify sensitivities, and estimate disease burden.

LymphoTrack® Low Positive Control
The LymphoTrack® Low Positive Control is coming soon! This control, along with the LymphoQuant® and LymphoTrack® MRD bioinformatics software will aid in tracking of MRD in longitudinal studies.

Flow Cytometry
Stop splitting primary samples! You no longer have to split patient specimens as Invivoscribe will be able to offer combined flow cytometry and NGS-based biomarker testing in the near future.

Exhibit information:

Date: Jun 01 – June 03, 2019
Venue: McCormick Place – 2301 S King Dr., Chicago, IL 60616
Booth: #26127

Visit us at Booth #26127 and at our events to learn more. If you would like to arrange a meeting, contact us at support@invivoscribe.com.

Join us at ASCO June 1st to June 3rd to speak to our team about Invivoscribe’s new products and assay offerings!

LymphoQuant® Internal Control
Minimal Residual Disease (MRD) is being increasingly recognized as a biomarker and potential surrogate endpoint for a number of hematologic malignancies. We at Invivoscribe are excited to share details on the release of LymphoQuant® for use with our LymphoTrack® assays to assess sample quality, qualify sensitivities, and estimate disease burden.

LymphoTrack® Low Positive Control
The LymphoTrack® Low Positive Control is coming soon! This control, along with the LymphoQuant® and LymphoTrack® MRD bioinformatics software will aid in tracking of MRD in longitudinal studies.

Flow Cytometry
Stop splitting primary samples! You no longer have to split patient specimens as Invivoscribe will be able to offer combined flow cytometry and NGS-based biomarker testing in the near future.

Exhibit information:

Date: Jun 01 – June 03, 2019
Venue: McCormick Place – 2301 S King Dr., Chicago, IL 60616
Booth: #26127

Visit us at Booth #26127 and at our events to learn more. If you would like to arrange a meeting, contact us at support@invivoscribe.com.

SHARE THIS EVENT
UPCOMING

Invivoscribe Events

UPCOMING

Invivoscribe Events

2019-07-11T05:21:26+00:00